Both CD44 and DEC1 are pivotal in tumor biology, each contributing through distinct but often overlapping mechanisms, and together, they influence cancer stemness, metastasis, and resistance to therapy, highlighting their potential as therapeutic targets in cancer treatment. Here, CD44 is linked to cancer.